An inflammatory link in atherosclerosis and obesity: Co-stimulatory molecules

Andreas Zirlik, E. Lutgens

Research output: Contribution to journalReview articlepeer-review


Atherosclerosis and obesity-induced metabolic dysfunction are lipid-driven inflammatory pathologies responsible for a major part of cardiovascular complications. Immune cell activation as well as interactions between the different immune cells is dependent on and controlled by a variety of co-stimulatory signals. These co-stimulatory signals can either aggravate or ameliorate the disease depending on the stage of the disease, the cell-types involved and the signal transduction cascades initiated. This review focuses on the diverse roles of the most established co-stimulatory molecules of the B7 and Tumor Necrosis Factor Receptor (TNFR) families, ie the CD28/CTLA4-CD80/CD86 and CD40L/CD40 dyads in the pathogenesis of atherosclerosis and obesity. In addition, we will explore their potential as therapeutic targets in both atherosclerosis and obesity.

Original languageEnglish (US)
Pages (from-to)272-278
Number of pages7
Issue number3
StatePublished - 2015


  • Atherosclerosis
  • Co-stimulation
  • Obesity

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'An inflammatory link in atherosclerosis and obesity: Co-stimulatory molecules'. Together they form a unique fingerprint.

Cite this